Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00253136
Status:
COMPLETED
Last Update Posted:
2010-12-03
First Post:
2005-11-10
Brief Title:
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
Sponsor:
Janssen LP
Organization:
Janssen LP
Organization Data
Organization:
Janssen LP
Class:
INDUSTRY
Study ID:
CR006055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen LP
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None